Intensity Therapeutics Inc (INTS)
5.00
-0.10
(-1.96%)
USD |
NASDAQ |
May 20, 12:22
Intensity Therapeutics Price to Book Value: 7.052 for May 20, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 17, 2024 | 6.897 |
| May 16, 2024 | 7.193 |
| May 15, 2024 | 6.812 |
| May 14, 2024 | 6.234 |
| May 13, 2024 | 5.642 |
| May 10, 2024 | 5.642 |
| May 09, 2024 | 5.303 |
| May 08, 2024 | 5.289 |
| May 07, 2024 | 5.317 |
| May 06, 2024 | 5.289 |
| May 03, 2024 | 5.444 |
| May 02, 2024 | 5.642 |
| May 01, 2024 | 5.43 |
| April 30, 2024 | 5.501 |
| April 29, 2024 | 5.754 |
| April 26, 2024 | 5.536 |
| April 25, 2024 | 5.536 |
| April 24, 2024 | 5.628 |
| April 23, 2024 | 5.712 |
| April 22, 2024 | 5.501 |
| April 19, 2024 | 5.472 |
| April 18, 2024 | 5.374 |
| April 17, 2024 | 5.557 |
| April 16, 2024 | 5.783 |
| April 15, 2024 | 5.881 |
| Date | Value |
|---|---|
| April 12, 2024 | 6.474 |
| April 11, 2024 | 6.417 |
| April 10, 2024 | 6.431 |
| April 09, 2024 | 6.798 |
| April 08, 2024 | 6.756 |
| April 05, 2024 | 6.347 |
| April 04, 2024 | 6.572 |
| April 03, 2024 | 6.424 |
| April 02, 2024 | 6.488 |
| April 01, 2024 | 7.038 |
| March 28, 2024 | 5.416 |
| March 27, 2024 | 5.26 |
| March 26, 2024 | 5.552 |
| March 25, 2024 | 5.395 |
| March 22, 2024 | 5.614 |
| March 21, 2024 | 5.739 |
| March 20, 2024 | 5.458 |
| March 19, 2024 | 5.208 |
| March 18, 2024 | 5.052 |
| March 15, 2024 | 5.01 |
| March 14, 2024 | 4.333 |
| March 13, 2024 | 4.270 |
| March 12, 2024 | 4.593 |
| March 11, 2024 | 5.156 |
| March 08, 2024 | 5.562 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.809
Minimum
Nov 16 2023
9.031
Maximum
Jan 02 2024
4.765
Average
5.196
Median
Price to Book Value Benchmarks
| NovaBay Pharmaceuticals Inc | -- |
| Palatin Technologies Inc | 20.70 |
| iBio Inc | 0.7804 |
| Theriva Biologics Inc | 0.2080 |
| Oragenics Inc | 7.423 |
Price to Book Value Related Metrics
| Price | 5.00 |
| Earnings Yield | -43.43% |
| Market Cap | 68.56M |